While it is common for the business community to complain that government regulators are slowing the pace of commerce, a group of venture capitalists is saying that problems between medical-technology start-ups and the Food and Drug Administration — which must approve new drugs and devices before they hit the market — have grown much larger than the usual tug-of-war.
Reuters Medical technology start-up are going out of business as they wait for FDA guidance that sometimes takes years, if it comes at all, alleges the Medical Device Venture Council , made up of nine prominent venture firms that focus on medical technology. And many emerging companies that do stay in business are looking to launch in Europe, as the approval process in the U.S. is fraught with too many d
To read the full, original article click on this link: Is FDA Dysfunction Linked To Failed Start-Ups? - Venture Capital Dispatch - WSJ
